Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.
Chitra JosephSara Al-IzziMansour AlsaleemSasagu KurozumiMichael S TossMaariya ArshadFang Qin GohIbraheem M AlshankytyMohammed A AleskandaranySimak AliIan O EllisNigel P MonganAndrew R GreenEmad A RakhaPublished in: British journal of cancer (2019)
This study provides evidence for the prognostic value of RXRG in breast cancer particularly the ER-positive tumours.